Skip to main content
. 2023 Dec 7;99:104903. doi: 10.1016/j.ebiom.2023.104903

Table 1.

Information of BA.5 breakthrough infected individuals.

Patients Gender/age Symptomatic
Re-infection
Fever Cough Nasal congestion Sore throat Muscle soreness Tiredness
P1 F/27 + + + +
P2 F/26 +
P3 F/27 + + + +
P4 F/28 + + +
P5 F/27 + + + +
P6 F/26 + + +
P7 F/27 + + +
P8 M/29 + + +
P9 M/33 + + + +
P10 F/27 + + + +
P11 F/29 + + +
P12 F/35 + + +
P13 M/31 + + + +
P14 F/26 + + + +
P15 F/26 + + + +
P16 F/27 + + + + +
P17 F/30 + + + +
P18 M/28 + + +
P19 F/25 + + + + +
P20 M/45 + + +
P21 M/30 + + +
P22 M/33 + + + +
P23 F/27 + + + + /
P24 F/28 + + + + +
P25 M/26 + +
P26 M/29 + + + +
P27 M/24 + + + + + +
P28 M/26 + + + +
P29 M/28 + + + + +
P30 F/41 + + + +
P31 M/33 + + + + + +
P32 F/28 + + + + +
P33 F/34 + + + + + +

+: positive; −: negative; /: not tested.